A ground-breaking regional anaesthesia device, invented by clinicians at The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust (QEH) and developed in conjunction with medical device company Medovate, has been awarded ‘Patient Safety Innovation of the Year’ at this year’s HSJ Patient Safety Awards. The HSJ Patient Safety Awards celebrated the innovative work of frontline NHS teams in a year when the challenge and necessity of keeping the public safe ha

Medistar Corporation and Voyages Behavioral Health ("Voyages"; an affiliate of PAM Health) are pleased to announce the development of Voyages Behavioral Health of Pensacola, a state-of-the-art behavioral health hospital. When completed in 2022, Voyages Behavioral Health of Pensacola will be one of the first hospitals to integrate inpatient medical and psychiatric care. Identifiying a need in behavioral health services across the country, PAM Health established Voyages Beha

Squid Healthcare, Inc., a medical aesthetic company innovating periocular wellness for post-surgical and non-surgical procedures, announced today it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the EyeMask MD®. Pursuant to Section 510(k), once the application has been accepted, the FDA will conduct its substantive review and may request additional information. The company’s FDA submission is supported by biocompatibility

Pioneering radio frequency identification (RFID) theatre kitting technology, which streamlines the management of theatre supplies, could help reduce the elective surgery backlog caused by COVID-19. The pandemic continues to have a severe effect on waiting lists for elective surgery in the UK and RFiD Discovery, the UK’s leading location tracking specialist for healthcare, say its pioneering integrated ‘theatre kitting' solution can help to relieve some of the pressur

BD (Becton, Dickinson and Company), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS. While traditional vaccine formulations are commonly stored up to about 2°C-8°C, new vaccine formulations – including those for mRNA – require much colder storage for over a long period of time to ensure drug-product shelf-life and potency (1)(2). Such low temperatures c

Get Real Health, a member of the CPSI  family of companies and a provider of comprehensive patient engagement tools, has expanded its international presence through an implementation in the region of Achterhoek, Netherlands, together with local partners MIJNPGO and WeDoTrust. This implementation is meant to support the region’s ambition to become the healthiest region in the Netherlands by 2030. To that end, the project will have timed implementations and deployments aime

CARMAT , the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, announces the first implant of its bioprosthetic artificial heart, Aeson®, in a female recipient. The implant procedure was performed by a team led by Dr. Mark S. Slaughter, Professor and Chair of the Department of Cardiovascular and Thoracic Su

CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. Dr. Nicolette will review progress in development of the company’s allogeneic CAR-CIK technology platform for the treatment

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announces today that it has entered into a definitive agreement dated September 19, 2021 (the “Agreement”) to acquire Embark Health Inc. Embark has extensive manufacturing and intellectual property (“IP”) assets related to high-end solventless cannabis extracts, such as bubble has

To bring world-class, innovative cancer care to the Riverview area, Tampa General Hospital and Cancer Center of South Florida (CCSF) are opening a new TGH Cancer Institute location at 3140 S. Falkenburg Road, in Riverview. "Our new location will provide easier access to the same excellent care provided by our cancer experts on-site at Tampa General's main hospital campus, as well as important infusion treatments for cancer," said Dr. Abraham Schwarzberg, chief of oncol